Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01055444 · ClinicalTrials.gov registry record · Phase 2
Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement Syndrome
A Phase 2 study of Shoulder Impingement Syndrome, sponsored by ZARS Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01055444: Completed Phase 2 study of Shoulder Impingement Syndrome, sponsored by ZARS Pharma.
NCT01055444 is a Phase 2 study of Shoulder Impingement Syndrome that has completed, run by ZARS Pharma. The registered enrollment target is 20 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01055444, a Phase 2 study of Shoulder Impingement Syndrome, has completed, sponsored by ZARS Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to explore the potential usefulness of a heated lidocaine 70 mg/tetracaine 70 mg topical patch for the treatment of pain associated with shoulder impingement syndrome
Conditions Studied
Interventions
- DRUG Heated lidocaine and tetracaine topical patch
Study Locations (1)
Idaho
- Injury Care Medical Center - Boise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-09 |
| Phase | Phase 2 |
What the finished NCT01055444 record still lists
NCT01055444 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Shoulder Impingement Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Heated lidocaine and tetracaine topical patch is the first listed.
NCT01055444 reports a single indexed study location in Idaho.
Frequently Asked Questions
What is clinical trial NCT01055444 about?
NCT01055444 is a clinical study titled "Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement Syndrome". The purpose of the study is to explore the potential usefulness of a heated lidocaine 70 mg/tetracaine 70 mg topical patch for the treatment of pain associated with shoulder impingement syndrome
What is the current status of trial NCT01055444?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2010-03. Estimated completion is 2010-09.
What conditions does trial NCT01055444 study?
This clinical trial studies the following conditions: Shoulder Impingement Syndrome.
What interventions are being tested in trial NCT01055444?
The interventions under investigation include: Heated lidocaine and tetracaine topical patch (DRUG).
Who is sponsoring clinical trial NCT01055444?
This trial is sponsored by ZARS Pharma, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01055444 being conducted?
This trial has 1 study location across Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shoulder Impingement Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01055444's enrollment target sits among peer trials
20 1805th of 2000 higher than 107 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia